Skip to content

High Intensity Laser Versus Ischemic Compression on Myofascial Trigger Points in the Upper Trapezius

High Intensity Laser Versus Ischemic Compression on Myofascial Trigger Points in the Upper Trapezius

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06552780
Enrollment
63
Registered
2024-08-14
Start date
2024-05-19
Completion date
2025-02-01
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neck Pain

Keywords

myofascial pain syndrome trigger points high intensity laser ischemic compression

Brief summary

TO Investigate the effect of high intensity laser versus ischemic compression on myofascial trigger points on neck pain, cervical range of motion,pressure pain thershold and cervical disability and to show that the more effectivness therapy will provide significant clinical value

Detailed description

Randomized controlled Trial , participants will be assigned into three groups (study group A ,study group B and study group c ) Subject selection will be 63 subjects , 21 subjects in each group with trigger points in the upper trapezius. Groups

Interventions

DEVICETENs , ultrasound therapy

effect of high intensity laser versus ischemic compression on myofascial trigger points in the upper trapezius

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

participants will be divided into three groups of equal number group A , group B ,and group C ,the randomization will be performed by computerized randomization.

Intervention model description

Treatment

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* The age of patients range from 20 to 50 years . * patient Body mass index starting from 19 to 25 kg\\m. * presence of myofascial trigger points in the shortened upper trapezius muscle evaluated .

Exclusion criteria

* patients with fibromyalgia syndrome. * cancer or tumor or any type diagnosed . * patients with disc herniation or spinal canal stenosis. * pregnancy - * patients diagnosed with epilepsy.

Design outcomes

Primary

MeasureTime frameDescription
cervical range of motion (CROM)30 secondsAll the cervical active movements will be measured by cervical range of motion device (CROM) especially in cervical flexion ,extension and medial and lateral rotation.one tester will document the results. cervical range of motion (cROM) will be measured by using Electronic CROM Goniometer in all ranges.

Secondary

MeasureTime frameDescription
cervical painone minuteCervical pain will be measured by Cervical range of motion device (CROM) .The patient will actively perform cervical movements in flexion ,extension and medial and lateral rotation then one tester will document the results as VAS will be used to measure pain levels .The VAS is a 10\_cm line divided into 10 equal sections , with 10 expressing unbearable pain and 0 indicating no pain .each patient will be asked to point on this line to their level of neck pain .as pain level decreases ,the patient state improves. Pain will be assessed before and after treatment.

Other

MeasureTime frameDescription
pressure pain threshold (PPT)10 secondsPressure pain threshold (PPT) ,measured by Algometer is defined as the point at which painless stimulation such as pressure turns into a painful sensation,so that we will measure PPT for each patient before and after treatment by one tester as pressure Algometry is a method that objectively describes PPT

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026